My Quote Request
No products added yet
6505-01-359-8558
20 Products
NDC00033-2442-40
NICARDIPINE HYDROCH
NSN, MFG P/N
6505013598558
NSN
6505-01-359-8558
MFG
SYNTEX LABORATORIES INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 60 MG NICARDIPINE HYDROCHLORIDE; 60 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NICARDIPINE HYDROCHLORIDE EXTENDED RELEASE CAPSULES 60MG 60S BT
Related Searches:
F92A380
NITROGEN,USP
NSN, MFG P/N
6505013600908
NSN
6505-01-360-0908
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
(NON-CORE DATA) UNIT PACKAGE QUANTITY: 1
(NON-CORE DATA) UNIT PACKAGE TYPE: CYLINDER, TYPE H
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGEN USP GAS CYLINDER TYPE H 230 CUBIC FEET
PHYSICAL FORM: GAS
SPECIAL FEATURES: 230 CUBIC FEET OF NITROGEN, CGA 580 VALVE
Related Searches:
NITROGEN CYLINDER SIZE H
NITROGEN,USP
NSN, MFG P/N
6505013600908
NSN
6505-01-360-0908
NITROGEN CYLINDER SIZE H
NITROGEN,USP
NSN, MFG P/N
6505013600908
NSN
6505-01-360-0908
MFG
LIQUID AIR CORP
Description
(NON-CORE DATA) UNIT PACKAGE QUANTITY: 1
(NON-CORE DATA) UNIT PACKAGE TYPE: CYLINDER, TYPE H
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGEN USP GAS CYLINDER TYPE H 230 CUBIC FEET
PHYSICAL FORM: GAS
SPECIAL FEATURES: 230 CUBIC FEET OF NITROGEN, CGA 580 VALVE
Related Searches:
UN1066
NITROGEN,USP
NSN, MFG P/N
6505013600908
NSN
6505-01-360-0908
MFG
LIQUID AIR CORP
Description
(NON-CORE DATA) UNIT PACKAGE QUANTITY: 1
(NON-CORE DATA) UNIT PACKAGE TYPE: CYLINDER, TYPE H
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGEN USP GAS CYLINDER TYPE H 230 CUBIC FEET
PHYSICAL FORM: GAS
SPECIAL FEATURES: 230 CUBIC FEET OF NITROGEN, CGA 580 VALVE
Related Searches:
812-84
TETANUS TOXOID,USP
NSN, MFG P/N
6505013602176
NSN
6505-01-360-2176
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS TOXOID USP 15 DOSES PER VIAL 75ML VIAL
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 15 DOSES
SPECIAL FEATURES: FLUID OR PLAIN
Related Searches:
F92E084
TETANUS TOXOID,USP
NSN, MFG P/N
6505013602176
NSN
6505-01-360-2176
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS TOXOID USP 15 DOSES PER VIAL 75ML VIAL
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 15 DOSES
SPECIAL FEATURES: FLUID OR PLAIN
Related Searches:
NDC49281-0812-84
TETANUS TOXOID,USP
NSN, MFG P/N
6505013602176
NSN
6505-01-360-2176
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS TOXOID USP 15 DOSES PER VIAL 75ML VIAL
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 15 DOSES
SPECIAL FEATURES: FLUID OR PLAIN
Related Searches:
7104-3
THROMBIN,USP
NSN, MFG P/N
6505013604509
NSN
6505-01-360-4509
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
DERIVATION: BOVINE
DILUTING AGENT: ANY ACCEPTABLE
QUANTITY WITHIN EACH UNIT PACKAGE: 10000.0 UNITS
SPECIAL FEATURES: 10 VIALS PER PACKAGE; DILUTING AGENT: STERILE WATER
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: ANY ACCEPTABLE
Related Searches:
NDC00053-7104-03
THROMBIN,USP
NSN, MFG P/N
6505013604509
NSN
6505-01-360-4509
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
DERIVATION: BOVINE
DILUTING AGENT: ANY ACCEPTABLE
QUANTITY WITHIN EACH UNIT PACKAGE: 10000.0 UNITS
SPECIAL FEATURES: 10 VIALS PER PACKAGE; DILUTING AGENT: STERILE WATER
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: ANY ACCEPTABLE
Related Searches:
THROMBINAR
THROMBIN,USP
NSN, MFG P/N
6505013604509
NSN
6505-01-360-4509
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
DERIVATION: BOVINE
DILUTING AGENT: ANY ACCEPTABLE
QUANTITY WITHIN EACH UNIT PACKAGE: 10000.0 UNITS
SPECIAL FEATURES: 10 VIALS PER PACKAGE; DILUTING AGENT: STERILE WATER
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: ANY ACCEPTABLE
Related Searches:
A92E176
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
A92E176
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
NDC00115-7043-01
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
NDC00115-7043-01
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
RICHLYN LABORATORIES INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
NDC58177-0050-04
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
NDC58177-0050-04
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
ETHEX CORP SUB OF K-V PHARMACEUTICAL CO
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
NDC58914-0004-10
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
NDC58914-0004-10
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
AXCAN PHARMA US INC.
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
ULTRASE MT20
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
ULTRASE MT20
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
AXCAN PHARMA US INC.
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
ULTRASE MT20 CAPSULES
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
ULTRASE MT20 CAPSULES
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013605739
NSN
6505-01-360-5739
MFG
AXCAN PHARMA US INC.
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
Related Searches:
AXID
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605743
NSN
6505-01-360-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 150MG 60S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 150 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
Related Searches:
AXID CAPSULES
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605743
NSN
6505-01-360-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 150MG 60S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 150 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
Related Searches:
NDC00002-3144-60
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605743
NSN
6505-01-360-5743
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 150MG 60S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 150 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
Related Searches:
AXID
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605744
NSN
6505-01-360-5744
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 300MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 300 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
